Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 429,647 | 421,026 | 337,277 | 286,630 | 276,371 |
| Cost of Goods | 117,328 | 106,712 | 86,845 | 87,915 | 110,104 |
| Gross Profit | 312,319 | 314,314 | 250,432 | 198,715 | 166,267 |
| Operating Expenses | 266,297 | 304,546 | 235,362 | 224,567 | 198,395 |
| Operating Income | 46,350 | 10,480 | 15,915 | -24,937 | -32,024 |
| Interest Expense | 25,671 | 23,628 | 21,949 | 18,047 | 7,061 |
| Other Income | -590 | 2,400 | 5,609 | 513 | 1,241 |
| Pre-tax Income | 20,089 | -10,748 | -425 | -42,471 | -37,844 |
| Income Tax | -125,434 | 268 | 46 | 140 | 105 |
| Net Income Continuous | 145,523 | -11,016 | -471 | -42,611 | -37,949 |
| Net Income | $145,523 | $-11,016 | $-471 | $-42,611 | $-37,949 |
| EPS Basic Total Ops | 3.41 | -0.27 | -0.01 | -1.07 | -1.02 |
| EPS Basic Continuous Ops | 3.41 | -0.27 | -0.01 | -1.07 | -1.02 |
| EPS Diluted Total Ops | 3.33 | -0.27 | -0.01 | -1.07 | -1.02 |
| EPS Diluted Continuous Ops | 3.33 | -0.27 | -0.01 | -1.07 | -1.02 |
| EPS Diluted Before Non-Recurring Items | 1.30 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $86,668 | $45,509 | $43,469 | $567 | $-14,538 |